美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunovant, Inc.

6.86

0.0000

成交量：- -

成交額：- -

市值：4.32億

市盈率：-7.79

高：6.86

開：6.86

低：6.86

收：6.86

52周最高：8.01

52周最低：0.2100

股本：6,301.48萬

流通股本：1,144.80萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.8810

每股收益(LYR):-0.6309

淨資產收益率：--

總資產收益率：--

市淨率：3.86

市盈率(LYR):-10.87

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Immunovant, Inc.盤中異動股價大漲5.19%

Immunovant, Inc.2025財年第三財季實現淨利潤-1.27億美元，按年減少16.51%

Immunovant, Inc.盤中異動早盤股價大漲5.29%

Immunovant, Inc.盤中異動早盤股價大跌5.22%報22.13美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IMVTW"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMVTW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTW\",,,,,undefined,":{"symbol":"IMVTW","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":6.86,"timestamp":1592251200000,"preClose":6.86,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":11447972,"shares":63014824,"eps":-0.881038,"marketStatus":"停牌","change":0,"latestTime":"06-15 16:00:00 EDT","open":6.86,"high":6.86,"low":6.86,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.881038,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.86,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMVTW\",,,,,undefined,":{"symbol":"IMVTW","floatShares":11447972,"roa":"--","roe":"--","lyrEps":-0.630873,"shares":63014824,"dividePrice":0,"high":6.86,"amplitude":0,"preClose":6.86,"low":6.86,"week52Low":0.21,"pbRate":"3.86","week52High":8.01,"institutionHeld":0,"latestPrice":6.86,"eps":-0.881038,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.881038,"open":6.86,"prevYearClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMVTW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-02-14","symbol":"IMVTW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1581656400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMVTW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMVTW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMVTW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606201967","title":"Immunovant, Inc.盤中異動 股價大漲5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606201967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606201967?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 01:54","pubTimestamp":1769450085,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日01时54分，Immunovant, Inc.股票出现波动，股价大幅上涨5.19%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Dermata Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Dermata Therapeutics, Inc.、Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为699.92%、122.26%、82.20%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Acumen Pharmaceuticals, Inc.，振幅分别为110.14%、43.46%、41.91%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127015445a6af3dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127015445a6af3dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","IMVT","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2584640929","title":"Immunovant, Inc.2025財年第三財季實現淨利潤-1.27億美元，按年減少16.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584640929","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584640929?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 00:01","pubTimestamp":1763308861,"startTime":"0","endTime":"0","summary":"11月17日，Immunovant, Inc.公布财报，公告显示公司2025财年第三财季净利润为-1.27亿美元，同比减少16.51%；其中营业收入为0.00美元，每股基本收益为-0.73美元。从资产负债表来看，Immunovant, Inc.总负债63.25百万美元，其中短期债务0.00美元，资产负债比为0.10，流动比率为0.10。机构评级：截至2025年11月17日，当前有15家机构对Immunovant, Inc.目标价做出预测，其中目标均价为38.73美元，其中最低目标价为16.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000121a4a5a940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2583766535","title":"Immunovant, Inc.盤中異動 早盤股價大漲5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583766535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583766535?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 22:44","pubTimestamp":1762958667,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时44分，Immunovant, Inc.股票出现异动，股价大幅拉升5.29%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。消息层面，截至22时44分，《H.C. Wainwright维持Immunovant买入评级，维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112224428a6f4b9a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4139","BK4588","IMVT","BK4585","IMVTW"],"gpt_icon":0},{"id":"2582535542","title":"Immunovant, Inc.盤中異動 早盤股價大跌5.22%報22.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582535542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582535542?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:39","pubTimestamp":1762785542,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Immunovant, Inc.股票出现异动，股价急速下挫5.22%。截至发稿，该股报22.13美元/股，成交量10.5238万股，换手率0.06%，振幅6.47%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Immunovant, Inc.公司简介：Immunovant Inc是一家临床阶段的免疫学公司，致力于帮助自身免疫性疾病患者恢复正常生活。消息层面，截至22时39分，《H.C. Wainwright维持Immunovant买入评级，维持目标价35美元》资讯为影响Immunovant, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022390294fb9618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVTW","IMVTU","BK4585","BK4139","IMVT"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMVTW\",params:#limit:6,delay:false,,,undefined,":[]}}